Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Carcinoid tumours

S Janmohamed1, S R Bloom

  • 1Francis Fraser Laboratories, Department of Endocrinology, Royal Postgraduate Medical School, London, UK.

Postgraduate Medical Journal
|April 1, 1997
PubMed
Summary
This summary is machine-generated.

Long-acting somatostatin analogues, like octreotide, are key for managing carcinoid tumors and carcinoid syndrome. While effective, research continues into future analogues and other treatments for these slow-growing malignancies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Suprasellar germ cell tumours: specific problems and the evolution of optimal management with a combined chemoradiotherapy regimen.

Clinical endocrinology·2002
Same author

In vitro basal and GnRH-stimulated secretion of gonadotrophins reflects long-lasting modulatory effects, and peripheral levels are not predicted by pituitary responsiveness to GnRH.

European journal of endocrinology·1999
Same author

An uncoupling protein 2 gene variant is associated with a raised body mass index but not Type II diabetes.

Diabetologia·1999
Same author

Gonadotrophin-releasing hormone and oxytocin secretion from the hypothalamus in vitro during pro-oestrus: the effects of time of day and melatonin.

Brain research bulletin·1999
Same author

The effects of various peptides on human isolated gut muscle.

The Journal of pharmacy and pharmacology·1992
Same author

The presence, characterisation and synthesis of neuromedin B in the human pituitary gland.

Neuroendocrinology·1992
Same journal

Two cases of toxic epidermal necrolysis with severe ocular involvement treated with adjunctive tofacitinib.

Postgraduate medical journal·2026
Same journal

Diastolic dysfunction and diabetes: the DIADAD study-a retrospective cohort study from Liverpool.

Postgraduate medical journal·2026
Same journal

Care, cash, and proof: forensic accountability for war-related starvation.

Postgraduate medical journal·2026
Same journal

Response to traumatic injuries in polo players in England.

Postgraduate medical journal·2026
Same journal

Aids to venesection and parenteral drug administration in patients with difficult veins.

Postgraduate medical journal·2026
Same journal

Diagnostic reasoning in clinical neurology: a comprehensive primer.

Postgraduate medical journal·2026
See all related articles

Area of Science:

  • Endocrinology
  • Oncology
  • Pharmacology

Background:

  • Carcinoid tumors are slow-growing neuroendocrine neoplasms.
  • Malignant carcinoid syndrome presents with significant symptoms.
  • Gastric carcinoids are linked to chronic hypergastrinemia, exacerbated by acid-suppressing medications.

Purpose of the Study:

  • To review the current management of carcinoid tumors.
  • To highlight the role of somatostatin analogues in treatment and diagnosis.
  • To discuss palliative interventions and future therapeutic prospects.

Main Methods:

  • Review of current literature on carcinoid tumor management.
  • Analysis of the efficacy and application of somatostatin analogues, particularly octreotide.
  • Discussion of palliative surgical and medical interventions.

Related Experiment Videos

Main Results:

  • Long-acting somatostatin analogues, notably octreotide, are effective for symptom control in malignant carcinoid syndrome.
  • Octreotide serves dual roles in therapy and diagnosis.
  • Gastric carcinoids' association with hypergastrinemia warrants attention.
  • Palliative surgeries (hepatic, cardiac) and interferons have roles in advanced disease.
  • Chemotherapy generally offers limited benefit.

Conclusions:

  • Somatostatin analogues represent a significant advancement in carcinoid tumor management.
  • Ongoing research into novel analogues with distinct receptor profiles and pharmacokinetics is promising.
  • A multidisciplinary approach involving palliative interventions is crucial for long-term patient care.